A decision tree model integrating ultrasound sliding sign optimizes surgical planning for stage IV endometriosis: an ambispective cohort study

Endometriosis is a chronic condition where preoperative stratification of disease severity is crucial for optimizing surgical planning and resource allocation. The objective of our study was to

Revisiting oncofertility outcomes: what the Society for Assisted Reproductive Technology can and cannot tell us about cryopreserved oocyte utilization

It is well established that reproductive aged patients facing a new cancer diagnosis should be offered timely counseling and a discussion about fertility preservation options before initiation of

Response to the comment on “Validity of completely omitting endocrine and ultrasound monitoring in hormone replacement therapy protocols for frozen embryo transfer in good-prognosis patients undergoing single blastocyst transfer”

We appreciate Dr. Iga’s comments on our article,“Validity of completely omitting endocrine and ultrasound monitoring in hormone replacement therapy protocols for frozen embryo transfer in

Is the uterus from the “Normal UteRus asSEssment study” truly normal?

The article by Gergolet et al. (1) provides an accurate morphometric mapping of the uterus in nulliparous women, establishing reference percentiles for measures of lengths, thicknesses, and

Invited Editorial Beyond Thickness: Rethinking Cesarean Scar Integrity Through Structure, Biology, and Surgical Insight

Fragility index analysis for robustness of evidence in randomized controlled trials leading to the US Food and Drug Administration approval of pharmacological therapies for endometriosis

Endometriosis is a chronic, estrogen-dependent condition affecting approximately 10% of reproductive-aged women and is a major cause of pelvic pain and infertility. The US Food and Drug

A placebo does not make a follicle grow

Ovarian stimulation, a critical component of in vitro fertilization cycles for multifollicular recruitment, is traditionally facilitated with high-dose gonadotropins. In the United States, this

Low return to care rates among women who underwent oocyte cryopreservation for oncological indications: a Society for Assisted Reproductive Technology data analysis

An estimated 84,100 adolescents and young adults (ages 15–39 years) were diagnosed with cancer in the United States in 2024. Although treatments are becoming more efficacious, they may pose risk

Leveraging reproductive biology mechanisms to protect fertility after chemotherapy

We commend Houeis et al. (1) on their randomized controlled trial suggesting that temsirolimus and antimüllerian hormone (AMH) potentially can protect against chemotherapy-induced ovarian toxicity

Reimagining the funding model for reproductive endocrinology and infertility fellowship training programs

Rates of infertility and the demand for assisted reproductive technology continues to rise in the United States. Despite increasing need for highly specialized fertility care, there is a national